Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - LONG-TERM INVESTMENTS
Long-term Investments KROS - Keros Therapeutics, Inc.
1.21 M
LAST VALUE
-4.43%
2 YEAR CAGR
19.33%
5 YEAR CAGR
0.00%
10 YEAR CAGR